LifeStance Health Group, Inc. (LFST)
NASDAQ
12.16
-0.31 (-2.49%)
Closed
Aug 24, 2026
Day's Range
12.1112.65
52 wk Range
4.7712.96
Financial Statements - LFST - LifeStance Health Group, Inc.
Revenue
1.42B▲ 13.9%
Net Income
9.66M▲ 116.8%Net Margin 0.7%
EBITDA
78.77M▲ 102.1%
Free Cash Flow
110.02M▲ 28.4%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|
| Sales | 1.42B | 1.25B | 1.05B | 859.54M | 667.51M | 212.51M |
| Cost of Goods | 963.18M | 848.57M | 753.56M | 622.52M | 466M | 150.12M |
| Gross Profit | 461.09M | 402.39M | 302.09M | 237.01M | 201.50M | 62.39M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 24.14M | -31.61M | -189.13M | -210.17M | -286.35M | 15.24M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -123K | 535K | 3.77M | -2.62M | -7.84M | -1.95M |
| Pre Tax Income | 12.36M | -57.61M | -206.58M | -232.73M | -333.10M | 7.87M |
| Income Tax | 2.70M | -170K | -20.32M | -17.16M | -25.90M | 2.20M |
| Net Income | 9.66M | -57.44M | -186.26M | -215.56M | -307.19M | 5.66M |
| EPS Basic | 0.03 | -0.15 | -0.51 | -0.61 | -1.05 | -0.157645 |
| EPS Diluted | 0.02 | -0.15 | -0.51 | -0.61 | -1.05 | -0.157645 |
| Basic Shares Outstanding | 386.01M | 379.14M | 367.45M | 355.27M | 327.52M | 373.64M |
| Diluted Shares Outstanding | 386.01M | 379.14M | 367.45M | 355.27M | 327.52M | 373.64M |
| Ebit | 24.02M | -31.07M | -185.36M | -212.80M | -294.19M | 13.28M |
| Ebitda | 78.77M | 38.97M | -108.80M | -141.19M | -233.68M | 21.33M |
| Net Income Continuous Operations | 9.66M | -57.44M | -186.26M | -215.56M | -307.19M | 5.66M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | - | 0 | 0 | 36.75M | 62.97M |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
